CCR Translation for This Article from Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors

Authors :: Josep Tabernero
José Baselga
Maria Josepa Carreras
Erik A.C. Wiemer
Yoshiharu Mizui
Maja J.A. de Jonge
Adelaida Piera
James P. O'Brien
Herman Burger
Francisco J. Ramos
Ferry A.L.M. Eskens
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: CCR Translation for This Article from Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors

Full Text Access

Tools